2015 to 2018 Saw Decrease in HPV Infections Among Young Women
FRIDAY, March 26, 2021 -- There have been significant declines in vaccine-type human papillomavirus (HPV) infections among both vaccinated and unvaccinated adolescent girls and young adult women, according to research published in the March 26 issue... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - March 26, 2021 Category: Pharmaceuticals Source Type: news

HPV Infections Are Plummeting Due to Widespread Vaccination
FRIDAY, March 26, 2021 -- Fifteen years of widespread vaccination of U.S. children with the human papillomavirus (HPV) vaccine is reaping big rewards: A more than 80% drop in new infections has been seen in women and girls under the age of 25. That... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - March 26, 2021 Category: General Medicine Source Type: news

HPV vaccine has led to more than 80% drop in infections, CDC reports
Introduction of the human papillomavirus vaccine in the United States has led to a more than 80% decline in infections nationally since 2003, according to data released Thursday by the CDC. (Source: Health News - UPI.com)
Source: Health News - UPI.com - March 25, 2021 Category: Consumer Health News Source Type: news

Call to Eradicate All Types of HPV Cancers, not Just Cervical Call to Eradicate All Types of HPV Cancers, not Just Cervical
Widespread gender-neutral vaccination against human papilloma virus (HPV) would eliminate HPV infections that cause many different cancer types, not just cervical cancer.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - March 25, 2021 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Declines in Prevalence of Human Papillomavirus Vaccine-Type Infection Among Females after Introduction of Vaccine - United States, 2003-2018
This report describes declines in HPV vaccine-type infection prevalence among females when compared with prevalence before vaccination. (Source: CDC Morbidity and Mortality Weekly Report)
Source: CDC Morbidity and Mortality Weekly Report - March 25, 2021 Category: American Health Tags: MMWR Morbidity & Mortality Weekly Report Source Type: news

HPV vaccine not cost-effective for adults age 26 to 45, study finds
Vaccination against human papillomavirus provides limited health benefits for adults aged 26 years and older at a high cost to the healthcare system, according to a study published Thursday by PLOS Medicine. (Source: Health News - UPI.com)
Source: Health News - UPI.com - March 11, 2021 Category: Consumer Health News Source Type: news

HPV vaccines for adults over age 26 may not be cost-effective
(Harvard T.H. Chan School of Public Health) Two simulation models suggest that vaccinating adults older than age 26 against human papillomavirus (HPV) would provide limited health benefit, at a substantial cost (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - March 11, 2021 Category: Cancer & Oncology Source Type: news

HPV vaccine may not be cost-effective in adult populations aged over 26 years
This study suggests that HPV vaccination over age 26 years provides limited health benefits at a high cost. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - March 11, 2021 Category: Cancer & Oncology Source Type: news

St. Jude launches program to boost HPV cancer prevention across the globe
(St. Jude Children's Research Hospital) St. Jude is dedicating staff and resources to focus on the prevention of human papillomavirus (HPV)-related cancers around the world through HPV vaccine awareness programming. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - March 4, 2021 Category: Cancer & Oncology Source Type: news

Rwanda: Covid-19 - Pandemic Halts HPV Vaccination in Kigali
[New Times] Several challenges related to the Covid-19 pandemic have frustrated plans to roll out a vaccination programme aimed at eliminating cervical cancer causing Human Papillomavirus (HPV) for girls aged 12, The New Times can exclusively reveal. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - February 18, 2021 Category: African Health Source Type: news

Parental HPV Vaccine Hesitancy Increased During 2012 to 2018
TUESDAY, Feb. 9, 2021 -- From 2012 to 2018, there was an increase in the proportion of unvaccinated adolescents who received a recommendation for human papillomavirus (HPV) vaccination, but parental HPV vaccine hesitancy also increased, according to... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - February 9, 2021 Category: Pharmaceuticals Source Type: news

More Parents Balking at Giving Kids Cancer-Fighting HPV Vaccine
TUESDAY, Feb. 9, 2021 -- Although more teens are getting the human papillomavirus (HPV) vaccine, parents'hesitancy is growing, a new study finds. From 2012 to 2018, more doctors recommended their patients get vaccinated with the HPV vaccine --... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - February 9, 2021 Category: General Medicine Source Type: news

HPV vaccine study shows major geographic disparities in people receiving or completing doses to fight the cancer-causing disease
The human papillomavirus is the most common cause of cervical cancer. (Source: Washington Post: To Your Health)
Source: Washington Post: To Your Health - January 31, 2021 Category: Consumer Health News Authors: Erin Blakemore Source Type: news

Merck's Gardasil vaccine crippled a young man - an ongoing medical tragedy that must be stopped
(Natural News) Robert F. Kennedy Jr. and the Baum Hedlund Law Firm from Los Angeles, California have filed their fifth lawsuit against Merck, taking on the drug company’s dangerous and deceptive Gardasil vaccine, and standing up for innocent young people who have been disabled by the vaccine. The law firm is taking on Merck and... (Source: NaturalNews.com)
Source: NaturalNews.com - January 26, 2021 Category: Consumer Health News Source Type: news

We All Deserve Protection From Covid-19
Credit: United NationsBy Adaora OkoliNEW ORLEANS, US, Dec 11 2020 (IPS) When I contracted Ebola virus disease in August 2014 while working as a medical doctor in a well-known private hospital in Lagos, Nigeria, I was denied access to a potential cure. For 15 days, I battled for my life in a debilitated isolation ward, not knowing if I would survive. But American aid workers who contracted Ebola were administered Zmapp, a monoclonal antibody treatment, which reduces the relative risk of death from Ebola by 40% as well as shorten the duration of stay in the Ebola treatment units. They survived. We were told that Zmapp was e...
Source: IPS Inter Press Service - Health - December 11, 2020 Category: International Medicine & Public Health Authors: Adaora Okoli Tags: Headlines Health TerraViva United Nations Source Type: news

Increasing HPV vaccine uptake in adolescents
(University of Pennsylvania School of Nursing) More than 90 percent of human papillomavirus (HPV)-related cancers could be prevented by widespread uptake of the HPV vaccine. Yet, vaccine use in the United States falls short of public health goals. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - December 1, 2020 Category: Cancer & Oncology Source Type: news

Uganda: Uganda Yet to Embrace Hpv Vaccination
[Monitor] he magic bullet to stop the infamous cervical cancer rise, according to experts lies in Human papillomavirus (HPV) vaccination. Countries have since launched several vaccination campaigns as recommended by different world health bodies and specific organisations in the cancer battle. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - November 23, 2020 Category: African Health Source Type: news

Interventions to Increase HPV Vaccine Coverage Cost-Effective
MONDAY, Nov. 16, 2020 -- Three interventions for increased human papillomavirus (HPV) vaccine coverage are cost-effective, according to a study published online Nov. 16 in Pediatrics. Jennifer C. Spencer, Ph.D., from the Harvard T.H. Chan School of... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - November 16, 2020 Category: Pharmaceuticals Source Type: news

Black College Students, Especially Women, Delay HPV Vaccination Black College Students, Especially Women, Delay HPV Vaccination
The human papillomavirus (HPV) disproportionately affects people of color and Black gay men, yet many within these communities do not receive the HPV vaccine, most notably college-aged women of color.Medscape Medical News (Source: Medscape Hiv-Aids Headlines)
Source: Medscape Hiv-Aids Headlines - November 15, 2020 Category: Infectious Diseases Tags: Nursing News Source Type: news

HPV Vaccine Generally Well Tolerated in Males
WEDNESDAY, Nov. 4, 2020 -- Human papillomavirus (HPV) vaccines are safe and well tolerated in males, with few reports of adverse events, according to a study published online Nov. 3 in the British Journal of Clinical Pharmacology. Giulia Bonaldo,... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - November 4, 2020 Category: Pharmaceuticals Source Type: news

HPV Vaccination Remains Below Healthy People Goals HPV Vaccination Remains Below Healthy People Goals
Rates of human papillomavirus vaccination increased for both boys and girls in the United States over the past decade but remain below target levels and vary widely among states.Medscape Medical News (Source: Medscape Infectious Diseases Headlines)
Source: Medscape Infectious Diseases Headlines - October 14, 2020 Category: Infectious Diseases Tags: Pediatrics News Source Type: news

Quality Improvement Coaching for Human Papillomavirus Vaccination Coverage: A Process Evaluation in 3 States, 2018-2019
(Source: CDC Preventing Chronic Disease)
Source: CDC Preventing Chronic Disease - October 8, 2020 Category: International Medicine & Public Health Tags: Public Health Source Type: news

Impact of HPV vaccination mandates on social inequalities
(University of California - Riverside) A postdoctoral researcher at the University of California, Riverside, has discovered Human papillomavirus, or HPV, vaccination mandates fall short of ensuring both higher levels of uptake and equal uptake of the vaccine across socioeconomic and racial-ethnic groups. The findings could help facilitate equal access to and compliance with uptake of COVID-19 vaccines, once they are available. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - October 5, 2020 Category: Infectious Diseases Source Type: news

HPV Vaccination Tied to Decrease in Invasive Cervical Cancer Risk
THURSDAY, Oct. 1, 2020 -- Quadrivalent human papillomavirus (HPV) vaccination of girls and women aged 10 to 30 years is associated with a reduced risk for invasive cervical cancer, according to a study published in the Oct. 1 issue of the New... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - October 1, 2020 Category: Pharmaceuticals Source Type: news

HPV Vaccine Proves Its Mettle Against Cervical Cancer
WEDNESDAY, Sept. 30, 2020 -- Girls who are vaccinated against human papillomavirus (HPV) may drastically cut their chances of developing cervical cancer by age 30, a huge, new study finds. Researchers found that of more than 1.6 million young... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - September 30, 2020 Category: General Medicine Source Type: news

A Cross-Sectional Survey to Evaluate Potential for Partnering With School Nurses to Promote Human Papillomavirus Vaccination
(Source: CDC Preventing Chronic Disease)
Source: CDC Preventing Chronic Disease - September 24, 2020 Category: International Medicine & Public Health Tags: Public Health Source Type: news

Roche receives FDA approval for expanded use of the CINtec PLUS Cytology test to aid clinicians in preventing cervical cancer
Basel, 16 September 2020 — Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced U.S. Food and Drug Administration (FDA) approval for the expanded use of CINtec®PLUS Cytology, the first triage test based on biomarker technology for women whose cervical cancer screening results are positive for high-risk types of human papillomavirus (HPV). Additional information from this test supports clinical decisions about which women will benefit most from immediate follow-up. Laboratories can now use CINtecPLUS Cytology to triage positive results from the cobas ® HPV Test run on the fully integrated, automated and high-thr...
Source: Roche Media News - September 16, 2020 Category: Pharmaceuticals Source Type: news

Roche receives FDA approval for expanded use of the CINtec PLUS Cytology test to aid clinicians in preventing cervical cancer
Basel, 16 September 2020 — Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced U.S. Food and Drug Administration (FDA) approval for the expanded use of CINtec®PLUS Cytology, the first triage test based on biomarker technology for women whose cervical cancer screening results are positive for high-risk types of human papillomavirus (HPV). Additional information from this test supports clinical decisions about which women will benefit most from immediate follow-up. Laboratories can now use CINtecPLUS Cytology to triage positive results from the cobas ® HPV Test run on the fully integrated, automated and high-thr...
Source: Roche Investor Update - September 16, 2020 Category: Pharmaceuticals Source Type: news

HPV Vaccination Rates Increasing Among 15-Year-Olds
MONDAY, Sept. 14, 2020 -- From 2011 to 2017, there was an increase in the proportion of U.S. 15-year-olds with at least one-dose or two-dose human papillomavirus (HPV) vaccination, according to a study published online Sept. 14 in... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - September 14, 2020 Category: Pharmaceuticals Source Type: news

HPV Vaccination Rises Among U.S. Kids, But Many Still Unprotected
MONDAY, Sept. 14, 2020 -- More U.S. kids are getting a recommended vaccine that protects against several cancers -- but there is still much room for improvement, a new study finds. At issue is the vaccine against human papillomavirus (HPV). Certain... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - September 14, 2020 Category: General Medicine Source Type: news

HPV vaccination linked to lower risk of precancerous condition
(Wiley) Vaccination against the human papilloma virus (HPV) reduces the risk of a condition that often leads to cervical cancer, according to an analysis of Danish health registry data. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - August 5, 2020 Category: Cancer & Oncology Source Type: news

ACS Disagrees With CDC on HPV Vaccination in Adults ACS Disagrees With CDC on HPV Vaccination in Adults
The American Cancer Society's new guidance on human papillomavirus vaccination diverges from the Centers for Disease Control and Prevention's recommendations.Medscape Medical News (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - August 3, 2020 Category: Allergy & Immunology Tags: Hematology-Oncology News Source Type: news

Teen HPV Vaccination Rates Suboptimal
THURSDAY, July 30, 2020 -- Lack of parental intent to initiate and complete the human papillomavirus (HPV) vaccine series for adolescents is a major public health concern, according to a study published online July 21 in The Lancet Public... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - July 30, 2020 Category: Pharmaceuticals Source Type: news

HPV Shots: Safe and Effective, But Many Parents Still Hesitate
WEDNESDAY, July 29, 2020 -- More than a decade of research has shown that the human papillomavirus (HPV) vaccine protects against a host of cancers, yet a new study finds that only half of American teens complete the multiple-shot regimen. Why?... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - July 29, 2020 Category: General Medicine Source Type: news

American Cancer Society Updates HPV Vaccination Guidelines
WEDNESDAY, July 8, 2020 -- The American Cancer Society has updated guidelines on human papillomavirus (HPV) vaccination, emphasizing that vaccination should be routinely offered at age 9 to 12 years; the updated recommendations were published online... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - July 8, 2020 Category: Pharmaceuticals Source Type: news

Study: 'Anti-vaxxers' gain traction against HPV vaccine on Facebook
(University of Missouri-Columbia) One of the biggest social media sites -- Facebook -- has allowed " anti-vaxxers " to gain a stronger voice against the use of the human papillomavirus, or HPV, vaccine, according to a new study from a media expert at the University of Missouri. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - July 8, 2020 Category: Cancer & Oncology Source Type: news

School HPV vaccine policies could result in higher vaccination rates, reduction in cancers
FINDINGSA UCLA-led study has found that in 2 of 3 states and jurisdictions with policies that require students entering school to receive the human papillomavirus vaccine, vaccination rates among 13-to-17-year-olds were significantly higher than in surrounding states without such policies.In Rhode Island, the vaccination rate among adolescents was 91%, compared with an average of 78% in neighboring non-policy states. In the District of Columbia, the rate was 89%, compared with 72% for nearby non-policy states. Virginia, which is in the same region as the district, was the one state with a vaccination policy that showed no ...
Source: UCLA Newsroom: Health Sciences - June 29, 2020 Category: Universities & Medical Training Source Type: news

Multilevel Interventions May Boost HPV Vaccination Rates
FRIDAY, June 19, 2020 -- Multilevel, provider-oriented interventions may improve human papillomavirus (HPV) vaccine series initiation and completion, according to a study published in the June 1 issue of Pediatrics. Rebecca B. Perkins, M.D., from... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - June 19, 2020 Category: Pharmaceuticals Source Type: news

FDA Approves HPV Vaccine Gardasil As Throat Cancer Prevention
The HPV vaccine (Gardasil 9) has been approved by the Food and Drug Administration (FDA) for males and females ages 9 to 45 years to prevent HPV-related genital tract and anogenital infections and cancers for several years. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - June 17, 2020 Category: Pharmaceuticals Authors: Nina Shapiro, Contributor Tags: Healthcare /healthcare Innovation /innovation Source Type: news

Gardasil-9 Approved for Prevention of Head and Neck Cancers Gardasil-9 Approved for Prevention of Head and Neck Cancers
The FDA has expanded the indication for the Gardasil-9 vaccine to include the prevention of head and neck cancersMedscape Medical News (Source: Medscape FamilyMedicine Headlines)
Source: Medscape FamilyMedicine Headlines - June 15, 2020 Category: Primary Care Tags: Hematology-Oncology News Source Type: news

Multilevel interventions improve HPV vaccination rates of series initiation and completion
(Boston Medical Center) New research from Boston Medical Center shows that providing education and training to pediatric and family medicine providers about the importance of human papillomavirus (HPV) vaccines, in tandem with healthcare systems changes including starting an HPV vaccination series before the age of 11, improves the overall rate of HPV vaccinations among adolescent patients. HPV vaccinations can help reduce rates of HPV-related cancers, as well as play a role in reducing race- and income-related disparities. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 15, 2020 Category: Cancer & Oncology Source Type: news

FDA Approves Merck ’s Gardasil 9 for the Prevention of Certain HPV-Related Head and Neck Cancers
KENILWORTH, N.J.--(BUSINESS WIRE) June 12, 2020 -- Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration (FDA) has approved an expanded indication for Gardasil 9 for the... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - June 15, 2020 Category: Drugs & Pharmacology Source Type: news

HPV Vaccines That Work in U.S. Women May Miss the Target in Women From Other Countries
A research team at Dartmouth’s and Dartmouth-Hitchcock’s Norris Cotton Cancer Center has found that the same vaccination programs that target human papillomavirus (hrHPV) strains in the United States may not be as effective in protecting other populations of women from the disease. (Source: News at Dartmouth Medical School)
Source: News at Dartmouth Medical School - June 4, 2020 Category: Hospital Management Authors: NonPerson Geisel Web Service Acct Tags: News Press Release cancer Norris Cotton Cancer Center Source Type: news

Wording of vaccination messages influences behavior
(Washington State University) An experiment by Washington State University researchers revealed that relatively small differences in messages influenced people's attitudes about the human papillomavirus or HPV vaccine, which has been shown to help prevent cancer. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 4, 2020 Category: International Medicine & Public Health Source Type: news

HPV vaccines that work in US women may miss the target in women from other countries
(Dartmouth-Hitchcock Medical Center) Most cervical cancers are caused by persistent infection with high-risk human papillomavirus (hrHPV). Different vaccines are available to protect against HPV. Researchers at Dartmouth's and Dartmouth-Hitchcock's Norris Cotton Cancer Center have shown a very different prevalence of hrHPV in Honduras compared to the United States, and concluded that the same vaccination programs that target hrHPV strains in the U.S. may not be as effective in protecting women in other countries from the disease. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 4, 2020 Category: Cancer & Oncology Source Type: news

Polio, Measles Outbreaks ‘Inevitable’, Say Vaccine Experts
A young boy in Pakistan receives an oral polio vaccine (OPV). Credit: Ashfaq Yusufzai/IPSBy Laura MackenzieMay 6 2020 (IPS) Interruptions to vaccination programmes caused by the COVID-19 pandemic could result in new waves of measles or polio outbreaks, health experts warn. A growing number of one-off immunisation campaigns and national routine vaccine introductions are being delayed amid social distancing and other measures to curb the spread of SARS-CoV-2, leaving millions unprotected. With both preventive campaigns and routine immunisations impacted, “we’ll have an increasing number of children who will becom...
Source: IPS Inter Press Service - Health - May 6, 2020 Category: International Medicine & Public Health Authors: Laura Mackenzie Tags: Global Headlines Health TerraViva United Nations Source Type: news

Roche receives FDA approval for cobas HPV test for use on the cobas 6800/8800 Systems to identify women at risk for cervical cancer
             Basel, 21 April 2020 - Roche (SIX: RO, ROG; OTCQX:RHHBY) today announced US Food and Drug Administration (FDA) approval for the cobas ® HPV test for use on the fully automated, high-throughput cobas® 6800/8800 Systems. The cobas® HPV test identifies women at risk for cervical cancer by detecting the presence of high-risk human papillomavirus (HPV) DNA in cervical samples. Persistent high-risk HPV infections can develop into pre cancerous lesions and, if left untreated, these lesions can progress to cervical cancer.“The approval ...
Source: Roche Media News - April 21, 2020 Category: Pharmaceuticals Source Type: news

Human Papillomavirus Vaccination Estimates Among Adolescents in the Mississippi Delta Region: National Immunization Survey ‑Teen, 2015-2017
(Source: CDC Preventing Chronic Disease)
Source: CDC Preventing Chronic Disease - April 16, 2020 Category: International Medicine & Public Health Tags: Public Health Source Type: news

Therapeutic HPV vaccine may improve outcomes in advanced cervical cancer
(American Association for the Advancement of Science) Combining a therapeutic vaccine for human papilloma virus (HPV) with two standard chemotherapy drugs may extend survival in patients with advanced, recurrent cervical cancer, according to a phase 1/2 trial involving 77 patients. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - March 18, 2020 Category: Cancer & Oncology Source Type: news

Exploring Opportunities to Leverage Pharmacists in Rural Areas to Promote Administration of Human Papillomavirus Vaccine
(Source: CDC Preventing Chronic Disease)
Source: CDC Preventing Chronic Disease - March 12, 2020 Category: International Medicine & Public Health Tags: Public Health Source Type: news